Protective effect of carboxymethyl-glucan (CM-G) against DNA damage in patients with advanced prostate cancer
AUTOR(ES)
Magnani, Marciane, Castro-Gomez, Raul Jorge Hernan, Mori, Mateus Prates, Kuasne, Hellen, Gregório, Emerson Pereira, Libos Jr, Farid, Cólus, Ilce Mara de Syllos
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
26/11/2010
RESUMO
Carboxymethyl-glucan (CM-G) is a soluble derivative from Saccharomyces cerevisiae (1 → 3)(1 → 6)-β-D-glucan. The protective efficiency of CM-G against DNA damage in cells from patients with advanced prostate cancer (PCa), and undergoing Androgen Deprivation Therapy (ADT), was evaluated. DNA damage scores were obtained by the comet assay, both before and after treatment with CM-G. The reduction in DNA damage, ranging from 18% to 87%, with an average of 59%, was not related to the increased number of leukocytes in peripheral blood. The results demonstrate for the first time the protective effect of CM-G against DNA damage in patients with advanced PCa. Among smokers, three presented the highest reduction in DNA damage after treatment with CM-G. There was no observable relationship between DNA damage scores before and after treatment, and age, alcoholism and radiotherapy.
Documentos Relacionados
- Protective effect of glucan against visceral leishmaniasis in hamsters.
- Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice.
- Phase II study of sunitinib in men with advanced prostate cancer
- Lack of protection against bacterial infections in patients with advanced cancer treated by biologic response modifiers.
- Activation of the hedgehog pathway in advanced prostate cancer